Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Sélectionnez vos espèces et l'application
anti-Mouse (Murine) Anticorps:
anti-Rat (Rattus) Anticorps:
Vous arrivez à notre recherche pré-filtrée.
Human Polyclonal SPR Primary Antibody pour WB - ABIN520456
Lange, Geerts, Feith, Mocz, Koster, Bachmann: Novel interaction of ornithine decarboxylase with sepiapterin reductase regulates neuroblastoma cell proliferation. dans Journal of molecular biology 2014
Human Polyclonal SPR Primary Antibody pour ELISA, WB - ABIN562987
Balasubramanian, Deng, Doudney, Hampton, Kennedy: Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line. dans Neuropharmacology 2015
Human Polyclonal SPR Primary Antibody pour WB - ABIN653908
Maddens, Ghesquière, Vanholder, Demon, Vanmassenhove, Gevaert, Meyer: Chitinase-like proteins are candidate biomarkers for sepsis-induced acute kidney injury. dans Molecular & cellular proteomics : MCP 2012
The allele frequencies for the SPR c.596-2A > G (0.7%) polymorphism is not a major cause of Parkinson's disease in the Maltese.
We earlier presented evidence for a physical interaction between ODC (Montrer ODC1 Anticorps) and SPR and we showed that RNAi-mediated knockdown of SPR expression significantly reduced native ODC (Montrer ODC1 Anticorps) enzyme activity and impeded Neuroblastoma (Montrer ARHGEF16 Anticorps) cell proliferation.
new homozygous mutation in the SPR gene was found in two sisters with dopa-responsive dystonia
Authors identified SPR as a novel regulator of ODC (Montrer ODC1 Anticorps) enzyme activity and, based on clinical evidence, present a model in which SPR drives ODC (Montrer ODC1 Anticorps)-mediated malignant progression in neuroblastoma (Montrer ARHGEF16 Anticorps).
SPR-mediated reduction of sepiapterin and redox cycling occur by distinct mechanisms
this large association study for the SPR gene revealed no association for Parkinson disease worldwide.
We examine the sleep, sleep-wake rhythms, CSF (Montrer CSF2 Anticorps) neurotransmitters, and melatonin profile in a patient with sepiapterin reductase deficiency.
haploinsufficiency of SPR can be a rare cause of dopa-responsive dystonia
Although association of SPR to Parkinson's disease (PD) is not strong enough to support that this is the PARK3 gene, this study further implicates a role for SPR in idiopathic PD.
Genomic DNA revealed the same homozygous point mutation introducing a premature stop codon in the SPR gene in 2 siblings.
Our results suggest that the hypertension with fluctuation and bradycardia of Spr(-/-) mice would be caused by an imbalance of sympathetic and parasympathetic input and impaired nitric oxide production in endothelial cells.
biopterin contents in the brains of these knock-out mice were moderately decreased from postnatal day 0 (P0) and remained constant up to P21 (Montrer D4S234E Anticorps)
These data suggest an essential role of SPR in the biosynthesis of BH4, and that the SPR gene could be a candidate gene for PARK3.
this study demonstrates an important role of endothelial SPR in modulating tetrahydrobiopterin and nitric oxide bioavailability
This gene encodes an aldo-keto reductase that catalyzes the NADPH-dependent reduction of pteridine derivatives and is important in the biosynthesis of tetrahydrobiopterin (BH4). Mutations in this gene result in DOPA-responsive dystonia due to sepiaterin reductase deficiency. A pseudogene has been identified on chromosome 1.
, short chain dehydrogenase/reductase family 38C, member 1
, 7,8-dihydrobiopterin:NADP+ oxidoreductase
, Sepiapterin reductase
, sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)